Overview

Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of dapagliflozin on the incretin sensitivity of the pancreatic beta cell.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
AstraZeneca
Treatments:
Dapagliflozin
Incretins